Última Hora: "Valor de mercado de casas usadas aumenta o dobro do valor de casas novas - Observador" Mon, 24 Sep 2018 12:15:06 GMT    "Nuno Amado: "Os banqueiros tinham uma ideia de si superior à realidade" - PÚBLICO" Mon, 24 Sep 2018 06:41:00 GMT    "Como é que a Farfetch ganha terreno num mundo dominado pela Amazon - ECO Economia Online" Mon, 24 Sep 2018 06:05:36 GMT    "Altice aponta ilegalidades e "erros de facto e de direito" na multa milionária de Bruxelas - Jornal de Negócios - Portugal" Mon, 24 Sep 2018 10:30:05 GMT    "Autoestradas. Estudo defende portagens em função do tráfego - Expresso" Mon, 24 Sep 2018 10:52:35 GMT    "Manuel Pinho suspeito de recorrer a perdão fiscal para legalizar pagamentos do BES - Observador" Mon, 24 Sep 2018 08:05:11 GMT    "Empresa na Áustria está a transformar plástico usado em petróleo - Revista Sábado" Mon, 24 Sep 2018 11:22:23 GMT    "Concorrência brasileira aprova compra da EDP pela CTG ?sem restrições? - Jornal de Negócios - Portugal" Mon, 24 Sep 2018 10:19:00 GMT   "" Mon, 24 Sep 2018 12:46:59 GMT    "Cinco encapuzados armados roubaram Porsche e nove mil euros em Paços de Ferreira - Jornal Verdadeiro Olhar" Mon, 24 Sep 2018 09:57:14 GMT      Para mais notícias, clique aqui.

Área de Acesso
       
       
Lembrar Sempre 
(Login BolsaPT & Canal Forex)

Queda de
--10.00 (+0.97%) SCHERING PLOUGH C - [Ticker: SGP]Gráfico SCHERING PLOUGH C  Notícias SCHERING PLOUGH C  Download de Históricos Metastock SCHERING PLOUGH C e Outros  Análise Técnica SCHERING PLOUGH C  
Última Trade368,000Range 52 Semanas[0,000 - 0,000]
Hora da Última Trade2018-09-14 - 00:00:00Price-Target 1 Ano0,000
Variação--10.00 (+0.97%)Capitalização Bolsista0
Bid / AskN/AEPS0,00
Abertura378,000PER0,00%
Máximo378,000Pagamento Dividendo
Mínimo368,000Data Ex-Dividendo
Fecho Anterior378,000Yield
Volume420Volume Médio (3m)0
Nota: Os dados podem apresentar atraso de alguns minutos.
Ver cotações de outros activos

Intraday   5 dias   1 mes   3 meses   6 meses   1 ano   2 anos   5 anos   10 anos            Use este gráfico no seu website!
Gráfico de SCHERING PLOUGH C -  [Ticker: SGP]
Mudar para Gráfico de Análise Técnica Interactiva de SCHERING PLOUGH C

Últimos 10 Tópicos no Fórum sobre SCHERING PLOUGH C:
Não foram encontrados tópicos sobre SCHERING PLOUGH C [SGP], mas aconselha-se pesquisa no Fórum por tópicos relacionados com SCHERING PLOUGH C.

 Notícias sobre SCHERING PLOUGH C [SGP]:   (ordenadas por relevância)

Cleveland Post Gazette

Global Anti-Viral Drugs Market 2018-2025 Focuses On Top Players ...
Cleveland Post Gazette
The most important market players are Roche, Abbott, AstraZeneca, GlaxoSmithKline, Gilead, Johnson & Johnson, Cipla, Merck & Co, Bristol-Myers-Squibb, Schering-Plough. The report also demonstrates the latest improvements in the market that help in ...


Forbes

Pharma Billionaire Charged With Penny Stock Fraud
Forbes
Investigators allege an investor named Barry C. Honig served as the ringleader of the scheme. In each of three ... They sold that company, the developer of some of the first sustained release formulations, to Schering-Plough in 1986 for $836 million ...

e mais »

Marketing magazine Australia

Making sense out of madness ? how this marketer is making it look ...
Marketing magazine Australia
The client list was vast, with more than 60 charities and pharmaceutical companies across the UK and Canada, including WWF, Oxfam and Schering-Plough. But she realised this wasn't the right path for her. ?I wasn't interested in making something appealing.


La Montagne

La nouvelle vie du Biopôle Clermont-Limagne à Riom grâce aux ...
La Montagne
C'est l'exemple d'une reconversion réussie. À Riom, dans le quartier de la Varenne, à deux pas de la rocade, un vaste site de 4 hectares, dont 1,2 hectares de bâtiments, s'offre une seconde vie grâce aux sciences du vivant, depuis 2013. À l'époque ...


managementjournal24.com

Anti-Viral Drugs Market Segmentation Application, Technology ...
managementjournal24.com
Anti-Viral Drugs Market Summary. Global Anti-Viral Drugs Market Size, Share, Growth, Trends, Regional Outlook, and Forecasts, 2018 ? 2025' to its vast database of research reports. This intelligence study focuses on the current market trends and ...

e mais »

theperfectinvestor.com

Interferon Biosimilar Market Growth Forecast Analysis by ...
Zherald
Roche Biosidus Zydus Cadila Nanogen Amega Biotech Rhein Minapharm Biogenetics PROBIOMED 3sbio Amgen Bayer Schering Plough Merck and many more. For Market chain analysis, the report covers upstream raw materials, equipment, downstream client survey ...
Global Interferon Biosimilar Market Outlook 2018-PROBIOMED ...theperfectinvestor.com

todos os 3 artigos de notícias »

Anti-Viral Drugs 2018 Global Market Key Players - GlaxoSmithKline ...
Industry Today (press release)
Roche Abbott Gilead Johnson & Johnson Merck & Co Schering-Plough Cipla Bristol-Myers-Squibb AstraZeneca. Request for Sample Report @ https://www.wiseguyreports.com/sample-request/3330661-global-anti-viral-drugs-industry-market-research-report.

e mais »

greenenergy24.com

Global Interferon Biosimilar Market Outlook, Size, Status, and ...
greenenergy24.com
QYResearch.us presents a new market intelligence report on title ?Global Interferon Biosimilar Market Insights and Forecast to 2025?. The Interferon Biosimilar market research report studies the Interferon Biosimilar industry extensively w.r.t company ...

e mais »

Interferon Biosimilar Sales Market Revenue Market Share Forecast ...
Newszak (blog)
Interferon Biosimilar Sales Market report shares premium data and relevant insights giving current state of Interferon Biosimilar Sales industry to make this research significant tool by segmenting on the basis of product and application. Interferon ...

e mais »

Global Interferon Biosimilar Market Report: Revenue Status, Cost ...
Newszak (blog)
Interferon Biosimilar market status and outlook of global and major regions, from angles of manufacturers, regions, product types and end industries; this report analyses the top manufacturers in global and major regions, and splits the Interferon ...

e mais »

The Newsman

Global Interferon Biosimilar Market 2018 ? Roche, Biosidus, Zydus ...
The Newsman
A market study based on the Interferon Biosimilar Market across the globe, recently added to the repository of Market Research, is titled 'Global Interferon Biosimilar Market 2018'. The research report analyses the historical as well as present ...

e mais »

Reuters

Keytruda sales power Merck to quarterly beat
Reuters
(Reuters) - Drugmaker Merck & Co (MRK.N) reported better-than-expected first-quarter earnings on Tuesday, helped by a more than 150 percent rise in sales of blockbuster cancer drug Keytruda.


Interferon Biosimilar Market 2018-2025 by Economic/Political ...
Expert Herald (press release) (blog)
Interferon Biosimilar Market report provides complete evaluation for those who are looking for Business expand in various regions, manufacturers, New entrants in the industry, Professional organisation/solutions providers, Government bodies, financial ...

e mais »

Reuters

Merck, Schering-Plough set to complete merger
Reuters
NEW YORK (Reuters) - Merck & Co (MRK.N) and Schering-Plough Corp SGP.N said their $41.1 billion merger will be completed later on Tuesday, marking the close of the second huge deal in the pharmaceutical industry in recent weeks. Pfizer Inc (PFE.


The Pharmaceutical Journal

Hepatitis C: tackling the silent killer
The Pharmaceutical Journal
1997: The first alpha interferon, Schering-Plough's Intron A (interferon alpha-2B), is approved for treatment of hepatitis C in the UK. 1999: European blood services begin screening blood with nucleic acid amplification testing (NAT), because it ...

Para mais notícias sobre SCHERING PLOUGH C clique aqui:
Notícias de SCHERING PLOUGH C

Largura do Site:

 Imagem de Fundo:

Copyright@1998-2018 - BolsaPT.com, todos os direitos reservados.
Fórum de Bolsa Cotações de Bolsa Notícias de Bolsa Chat de Bolsa Disclaimer Recursos para Webmasters